
A healthy heart this Valentine’s Day-and every day
Promote heart health awareness for both patients and providers this Valentine’s Day and during the American Heart Association’s Go Red for Women month.
February is the month of love, and it has been aptly chosen as the American Heart Association’s (AHA)
Since the campaign began, there’s been a nearly 90 percent increase in awareness among women recognizing heart disease as the leading cause of death. Like men, women’s most common heart attack symptom is chest pain or discomfort. However, women are somewhat more likely than men to experience some ;other common symptoms, particularly shortness of breath, nausea/vomiting, and back or jaw pain.
Last week, I attended a luncheon where two prominent physicians from
The Journal of the American College of Cardiology published an
“Differentiation of constrictive pericarditis (CP) from restrictive cardiomyopathy (RCM) is a complex and often challenging process. Because CP is a potentially curable cause of heart failure and therapeutic options for RCM are limited, distinction of these two conditions is critical.”
For physicians, the first step to correctly distinguishing CHF is appreciating what the diagnostic test covers. Is it evaluation constriction, restriction, or both? For patients, the first step is knowing what questions to ask. What is being evaluated? Are both CP and RCM able to be assessed by the current diagnostic test?
According to the Houston Methodist physicians, not all diagnostic machines have the ability to assess restriction on a Doppler test. Therefore, physicians might be missing an entire half of the equation. The statistics are alarming, but the good news is that the AHA has identified
Patients should strive to follow these seven rules to reduce their risk of developing CHF. Physicians should discuss and encourage their patients to follow these guidelines, interact with other specialists, ask equipment manufacturers about the diagnostic capabilities, and attend continuing medical education. Combined, we can push the industry forward to better diagnose, detect and prevent CHF. Together, we can have healthy hearts for many Valentine’s Days, and years, to come.
Rachel V. Rose, JD, MBA, advises clients on compliance and transactions in healthcare, cybersecurity, corporate and securities law, while representing plaintiffs in False Claims Act and Dodd-Frank whistleblower cases. She also teaches bioethics at Baylor College of Medicine in Houston. Rachel can be reached through her website,
Newsletter
Optimize your practice with the Physicians Practice newsletter, offering management pearls, leadership tips, and business strategies tailored for practice administrators and physicians of any specialty.














